What the company does
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 2 clinical …
What the weekly tape is saying
PPBT closed the latest completed week at 1.00 ILA. The 4-week return is 0.0% and the 12-week return is 0.0%. Trend Signal is inactive, Market Dynamics is 1.01. Setup signature: Risk-first tape with a 28/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1.08 ILA
- Vs Trend Line
- -7.1%
- Fair Value
- 15.18 ILA
- Vs Fair Value
- -93.4%
- 52W High
- 5.70 ILA
- 52W Low
- 1.00 ILA
- Drawdown
- -82.5%
- Range Position
- 0.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- IL Healthcare
- Sector Rank
- 27 of 51
- Sector Percentile
- 48.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
IL Healthcare
- Tracked Peers
- 51
- 4W Rank
- 23 of 51
- Avg 1W
- -0.8%
- Avg 4W
- 1587.1%
- Trend Breadth
- 29.4%
- Positive MD
- 52.9%
IL Biotechnology
- Tracked Peers
- 15
- 4W Rank
- 8 of 15
- Avg 1W
- -1.8%
- Avg 4W
- 1691.9%
- Trend Breadth
- 33.3%
- Positive RS
- 26.7%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.01
- 4W MD Change
- 111.1%
- Relative Strength
- -55.20
- 4W RS Change
- 12.6%
- Expectation
- Negative
- Probability
- 25.50%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 950.1K
- 13W Average
- 1.0M
- 52W Average
- 14.3M
- Vs 13W
- 0.9x
- Vs 52W
- 0.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 0.0%
- 52W Volatility
- 12.2%
- Upside Weeks
- 11
- Downside Weeks
- 11
- Downside Breadth
- 21.2%
- Avg Gain / Loss
- 9.0% / -17.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- TLV
- Country
- IL
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- ILA
- Market Cap
- 18.6M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1.00 ILA | 0.0% | 1.08 ILA | 15.18 ILA | 1.01 | -55.20 | 950.1K | Off |
| 5 Jun 2026 | 1.00 ILA | 0.0% | 1.08 ILA | 15.56 ILA | 1.00 | -56.63 | 110.0K | Off |
| 29 May 2026 | 1.00 ILA | 0.0% | 1.09 ILA | 15.97 ILA | 0.79 | -60.44 | 201.0K | Off |
| 22 May 2026 | 1.00 ILA | 0.0% | 1.11 ILA | 16.37 ILA | 0.58 | -61.57 | 300.0K | Off |
| 15 May 2026 | 1.00 ILA | 0.0% | 1.11 ILA | 16.81 ILA | 0.48 | -63.19 | 100.0K | Off |
| 8 May 2026 | 1.00 ILA | 0.0% | 1.11 ILA | 17.24 ILA | 0.29 | -65.64 | 250.0K | Off |
| 1 May 2026 | 1.00 ILA | 0.0% | 1.12 ILA | 17.69 ILA | 0.30 | -66.25 | 781.8K | Off |
| 24 Apr 2026 | 1.00 ILA | 0.0% | 1.12 ILA | 18.19 ILA | 0.28 | -67.27 | 5.0M | Off |
| 17 Apr 2026 | 1.00 ILA | 0.0% | 1.12 ILA | 18.63 ILA | 0.15 | -69.06 | 50.0K | Off |
| 10 Apr 2026 | 1.00 ILA | 0.0% | 1.12 ILA | 19.09 ILA | 0.08 | -70.66 | 479.5K | Off |
| 3 Apr 2026 | 1.00 ILA | 0.0% | 1.12 ILA | 19.49 ILA | 0.05 | -70.25 | 661.5K | Off |
| 27 Mar 2026 | 1.00 ILA | 0.0% | 1.14 ILA | 19.87 ILA | 0.18 | -70.81 | 2.7M | Off |
| 20 Mar 2026 | 1.00 ILA | 0.0% | 1.23 ILA | 20.26 ILA | 0.24 | -73.40 | 1.5M | Off |
| 13 Mar 2026 | 1.00 ILA | 0.0% | 1.33 ILA | 20.72 ILA | 0.35 | -73.54 | 50.0K | Off |